Mycobacterial spindle cell pseudotumor of lymph nodes after receiving Bacille Calmette-Guerin (BCG) vaccination
Yin, H.-l.; Zhou, X.-j.; Wu, J.-p.; Meng, K.; Sun, Y.-m.
Chinese Medical Journal 117(2): 308-310
2004
ISSN/ISBN: 0366-6999 PMID: 14975224 Document Number: 570586
Document emailed within 1 workday
Related Documents
Basel, P.L.; Shrestha, I.B. 2012: Factors associated with dropout between Bacille Calmette Guerin (BCG) and measles vaccination in a village development committee of a district Journal of Nepal Health Research Council 10(21): 147-151Lin, C.J.; Yang, W.S.; Yan, J.J.; Liu, C.C. 1999: Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis: a case report Journal of Bone and Joint Surgery. American Volume 81(9): 1305-1311
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Freedman, S.O. 1979: Bacille Calmette--Guérin in cancer...therapy? Canadian Medical Association Journal 121(1): 13
Al-Mendalawi, M.D.; Sharquie, K. 2008: Bacille Calmette-Guerin immunotherapy of viral warts Saudi Medical Journal 29(7): 1068; Author Reply 1068
Sharquie, K.E.; Al-Rawi, J.R.; Al-Nuaimy, A.A.; Radhy, S.H. 2008: Bacille Calmette-Guerin immunotherapy of viral warts Saudi Medical Journal 29(4): 589-593
Nissen, T.Nørrelykke.; Thøstesen, L.Marianne.; Birk, N.Marie.; Pihl, G.; Kjærgaard, J.; Stensballe, L.Graff. 2014: The bacille Calmette-Guérin vaccine may reduce the general child morbidity Ugeskrift for Laeger 176(9)
MacGregor, A.B.; Falk, R.E.; Landi, S.; Ambus, U.; Samuel, E.S.; Langer, B. 1977: Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin Canadian Journal of Surgery. Journal Canadien de Chirurgie 20(1): 25-30
Snider, T.G.; Pierce, K.R.; Adams, L.G. 1982: Response to neonatally thymectomized Holstein calves to bacille Calmette Guérin American Journal of Veterinary Research 43(8): 1363-1366
Smith, F.B.; Calmette, A.; Guérin, C. 1993: Tuberculosis and bureaucracy. Bacille Calmette et Guérin: its troubled path to acceptance in Britain and Australia Medical Journal of Australia 159(6): 408-411
Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Dunkley-Thompson, J.; Pierre, R.B.; Steel-Duncan, J.; Palmer, P.; Davis, D.; Figueroa, J.P.; Christie, C.D.C. 2008: Bacille Calmette-Guérin lymphadenitis and immune reconstitution syndrome in HIV-infected children on antiretroviral therapy in Jamaica West Indian Medical Journal 57(3): 302-306
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Cerdá de Palou, E.; de Santy, H.P.R.M. 2003: Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG) Nederlands Tijdschrift Voor Geneeskunde 147(12): 569-572
Zodpey, S.P.; Maldhure, B.R.; Kulkarni, S.W. 2004: Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis Journal of Communicable Diseases 36(3): 159-165
Venkataraman, M.; Kumar, R.; Bhuyan, U.N.; Malaviya, A.N.; Mohapatra, L.N. 1976: Immune responses in experimental tuberculosis after bacillus Calmette-Guerin vaccination and challenge with H37RV Indian Journal of Medical Research 64(11): 1581-1591
Martino, A.; Casetti, R.; Sacchi, A.; Poccia, F. 2007: Central memory Vgamma9Vdelta2 T lymphocytes primed and expanded by bacillus Calmette-Guérin-infected dendritic cells kill mycobacterial-infected monocytes Journal of Immunology 179(5): 3057-3064
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Hubay, C.A.; Pearson, O.H.; Marshall, J.S.; Rhodes, R.S.; Debanne, S.M.; Mansour, E.G.; Hermann, R.E.; Jones, J.C.; Flynn, W.J.; Eckert, C.; McGuire, W.L. 1980: Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report Surgery 87(5): 494-501
Hubay, C.A.; Gordon, N.H.; Crowe, J.P.; Guyton, S.P.; Pearson, O.H.; Marshall, J.S.; Mansour, E.G.; Hermann, R.E.; Jones, J.C.; Flynn, W.J. 1984: Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up Surgery 96(1): 61-72